NCT07139886View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration

PHASE2CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

March 14, 1997

Primary Completion Date

July 8, 1999

Study Completion Date

July 8, 1999

Conditions
Acute GastritisChronic Gastritis
Interventions
DRUG

Stillen® Tab

Oral administration 3 times per day (in-between meals and before sleep) for 2 weeks

DRUG

Stillen® Tab Placebo

Oral administration 3 times per day (in-between meals and before sleep) for 2 weeks

Trial Locations (1)

16499

Ajou University Medical Center, Division of Gastroenterology, Suwon

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY